We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

196 hedge funds and large institutions have $1.06B invested in Natus Medical Inc in 2016 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 73 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 24

1% more funds holding

Funds holding: 195196 (+1)

4% less capital invested

Capital invested by funds: $1.11B → $1.06B (-$41.8M)

5% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 73

46% less call options, than puts

Call options by funds: $1.75M | Put options by funds: $3.27M

57% less funds holding in top 10

Funds holding in top 10: 73 (-4)

Holders
196
Holders Change
+1
Holders Change %
+0.51%
% of All Funds
5.23%
Holding in Top 10
3
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-57.14%
% of All Funds
0.08%
New
27
Increased
69
Reduced
73
Closed
24
Calls
$1.75M
Puts
$3.27M
Net Calls
-$1.52M
Net Calls Change
-$389K
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
151
UBS Group
Switzerland
$169K -$50.9K -1,277 -23%
PI
152
PineBridge Investments
New York
$165K -$439 -11 -0.3%
QT
153
Quantbot Technologies
New York
$156K +$159K +3,987 New
Parallax Volatility Advisers
154
Parallax Volatility Advisers
California
$146K -$320K -8,026 -68%
Federated Hermes
155
Federated Hermes
Pennsylvania
$135K -$54.6K -1,369 -28%
TRCT
156
Tower Research Capital (TRC)
New York
$131K +$55.8K +1,399 +73%
BlackRock
157
BlackRock
New York
$129K +$7.54K +189 +6%
IR
158
Invictus RG
Bermuda
$127K -$38.1K -956 -23%
ACM
159
Argentus Capital Management
Texas
$118K -$94.7K -2,373 -44%
Barclays
160
Barclays
United Kingdom
$96K +$95.7K +2,399 +5,331%
AIM
161
Acrospire Investment Management
Illinois
$92K -$19.9K -500 -18%
AG
162
Advisor Group
Arizona
$79K +$319 +8 +0.4%
Royal Bank of Canada
163
Royal Bank of Canada
Ontario, Canada
$75K -$187K -4,685 -71%
SEI Investments
164
SEI Investments
Pennsylvania
$75K +$61.3K +1,537 +404%
US Bancorp
165
US Bancorp
Minnesota
$67K -$12.2K -305 -15%
Victory Capital Management
166
Victory Capital Management
Texas
$66K -$10.7K -267 -14%
RCM
167
Riverhead Capital Management
Delaware
$59K -$4.7M -117,960 -99%
CTC
168
Central Trust Company
Missouri
$54K +$1.99K +50 +4%
LIA
169
LS Investment Advisors
Michigan
$53K
Creative Planning
170
Creative Planning
Kansas
$52K +$12.5K +314 +31%
IA
171
IFP Advisors
Florida
$50K +$36.8K +922 +258%
HDIM
172
Hanson & Doremus Investment Management
Vermont
$47K
CG
173
Cutler Group
California
$42K -$14.9K -374 -26%
Zurich Cantonal Bank
174
Zurich Cantonal Bank
Switzerland
$34K +$6.26K +157 +22%
VOYA Investment Management
175
VOYA Investment Management
Georgia
$24.4K -$7.51M -188,406 -23%

NTUS Hedge Fund Activity: Q3 2016 in Review

196 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q3 2016, worth a combined $1.06B — down 3.8% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new NTUS positions and 24 closed out — a net gain of 3 holders — while 69 added to existing stakes and 73 trimmed.

The largest buyer was Columbia Wanger Asset Management, opening a new position worth an estimated $10.6M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $23.5M sold.

  • 196 institutional investors held Natus Medical Inc (NTUS) as of Q3 2016, up from 195 in Q2 2016.
  • Funds reported $1.06B of Natus Medical Inc stock for Q3 2016, down 3.8% quarter-over-quarter.
  • 27 funds opened new Natus Medical Inc positions in Q3 2016 and 24 closed out, a net change of +3 holders.
  • The largest Natus Medical Inc buyer in Q3 2016 was Columbia Wanger Asset Management, an estimated $10.6M added.
  • The largest Natus Medical Inc seller in Q3 2016 was Point72 Asset Management, an estimated $23.5M sold.

Based on aggregated 13F filings for Q3 2016.